Rezultati pretraživanja
  1. prije 3 sata

    could produce much larger volumes at a reduced cost ‼️ we are the leader using . Breaking news:

  2. prije 8 sati

    Meet the Kemwell team at Annual Biologics Manufacturing Asia 2020 Singapore. To know more details contact the Kemwell team. . . Girish Joshi, PhD, Jaby Jacob, Sanjay Lodha, Rachit Gunderia .

  3. prije 19 sati
  4. Psyched to start new career with Viral Vectors team! BD for components and services, including vectors, related to and gene-modified . .

  5. prije 23 sata

    At Custom Pharma we are licensed for the manufacture of veterinary medication, we're working on some exciting projects so make sure you follow us and you can click the link below to sign up to our mailing list!

  6. 5. velj

    Nice, short summary of 3 keys in selecting a CDMO.

  7. 5. velj

    Kemwell’s team of experienced scientists strive to develop a robust, efficient, scaled up manufacturing process to deliver consistent product quality. . .

  8. 4. velj

    Compounding pharmacy regulations minimises patent risks while presenting new challenges to resolve.

  9. 4. velj

    . Receives Donation from Viralgen CDMO makes significant contribution in manufacturing capacity to serve children who suffer from ultra-rare genetic disorders Read more:

  10. 4. velj
  11. 4. velj

    EXPERTISE CHOSEN TO DELIVER 100% DATA DRIVEN - The strength of Quay is our people. We invest in the best. Only experts with strong scientific backgrounds, years of extensive knowledge underpins the service we deliver. Find out more

  12. 4. velj
  13. 4. velj
  14. 3. velj

    [SEQENS CDMO] The growth of the generic drug marketplace : A win-win for the industry and patients. Discover the analyse of Laurent Alexandre, Director, Proprietary APIs, at Seqens CDMO on our blog 👇

  15. 3. velj
  16. 3. velj

    Compounding pharmacy regulations minimises patent risks while presenting new challenges to resolve.

  17. 3. velj

    Breaking: Catalent to buy Orgenesis' biz Masthercell for $315m - story Insider

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.